These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11132108)

  • 1. The effect of oxidatively modified low-density lipoproteins on platelet aggregability and membrane fluidity.
    Vlasova II
    Platelets; 2000 Nov; 11(7):406-14. PubMed ID: 11132108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet activation by oxidatively modified low density lipoproteins.
    Ardlie NG; Selley ML; Simons LA
    Atherosclerosis; 1989 Apr; 76(2-3):117-24. PubMed ID: 2730708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of oxidized low density lipoproteins on ADP-induced platelet aggregation in plasma].
    Vlasova II; Vakhrusheva TV; Azizova OA; Lopukhin IuM
    Vopr Med Khim; 1998; 44(1):43-54. PubMed ID: 9575612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of oxidized low density lipoproteins on the structure of platelet membrane. Use of electron paramagnetic resonance].
    Vlasova II
    Biofizika; 1999; 44(2):272-80. PubMed ID: 10418677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of calcium, lanthanum, and temperature on the fluidity of spin-labeled human platelets.
    Sauerheber RD; Zimmermann TS; Esgate JA; VanderLaan WP; Gordon LM
    J Membr Biol; 1980; 52(3):201-19. PubMed ID: 6247493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of low density lipoprotein from insulin-dependent diabetic patients on platelet functions.
    Rabini RA; Staffolani R; Martarelli D; Fumelli P; Ravaglia F; Dousset N; Curatola G; Mazzanti L
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3770-4. PubMed ID: 10523028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of effects on platelet membrane fluidity by antibiotics in ESR spectra.
    Sakata S; Ueda J; Hirata M
    Chemotherapy; 1986; 32(4):374-8. PubMed ID: 3015503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Native and oxidized low density lipoproteins enhance platelet aggregation in whole blood.
    Tornvall P; Chirkova L; Toverud KD; Horowitz JD; Chirkov Y
    Thromb Res; 1999 Aug; 95(4):177-83. PubMed ID: 10498387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypochlorite modified LDL are a stronger agonist for platelets than copper oxidized LDL.
    Volf I; Roth A; Cooper J; Moeslinger T; Koller E
    FEBS Lett; 2000 Oct; 483(2-3):155-9. PubMed ID: 11042272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulating effect of biologically modified low density lipoproteins on ADP-induced aggregation of washed platelets persists in absence of specific binding.
    Volf I; Roth A; Moeslinger T; Cooper J; Schmid W; Zehetgruber M; Koller E
    Thromb Res; 2000 Mar; 97(6):441-9. PubMed ID: 10704653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of native and oxidatively modified low-density lipoproteins on platelet function.
    Naseem KM; Goodall AH; Bruckdorfer KR
    Platelets; 1997; 8(2-3):163-73. PubMed ID: 20297939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Native lipoproteins inhibit platelet activation induced by oxidized lipoproteins.
    Takahashi Y; Chiba H; Matsuno K; Akita H; Hui SP; Nagasaka H; Nakamura H; Kobayashi K; Tandon NN; Jamieson GA
    Biochem Biophys Res Commun; 1996 May; 222(2):453-9. PubMed ID: 8670226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of native and oxidatively modified low-density lipoproteins on platelet function.
    Platelets; 1997 Apr; 8(2):163-74. PubMed ID: 16793646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The aggregation of isolated human platelets in the presence of lipoproteins and prostacyclin.
    Hassall DG; Owen JS; Bruckdorfer KR
    Biochem J; 1983 Oct; 216(1):43-9. PubMed ID: 6360159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of lipid peroxidation-modified lipoproteins on thrombocyte aggregation].
    Azizova OA; Vlasova II
    Biull Eksp Biol Med; 1993 Nov; 116(11):485-7. PubMed ID: 8312535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidized low-density lipoprotein (LDL) enhances thromboxane A(2) synthesis by platelets, but lysolecithin as a product of LDL oxidation has an inhibitory effect.
    Mahfouz MM; Kummerow FA
    Prostaglandins Other Lipid Mediat; 2000 Jul; 62(2):183-200. PubMed ID: 10938412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified low-density lipoproteins and high-density lipoproteins. From investigation tools to real in vivo players.
    Koller E; Volf I; Gurvitz A; Koller F
    Pathophysiol Haemost Thromb; 2006; 35(3-4):322-45. PubMed ID: 16877881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ESR analysis with long-chain alkyl spin labels in bovine blood platelets. Relationship between the increase in membrane fluidity by alcohols and phenolic compounds and their inhibitory effects on aggregation.
    Kitagawa S; Kametani F; Tsuchiya K; Sakurai H
    Biochim Biophys Acta; 1990 Aug; 1027(2):123-9. PubMed ID: 2168753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mildly oxidized LDL induces platelet aggregation through activation of phospholipase A2.
    Weidtmann A; Scheithe R; Hrboticky N; Pietsch A; Lorenz R; Siess W
    Arterioscler Thromb Vasc Biol; 1995 Aug; 15(8):1131-8. PubMed ID: 7627706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and use of a new spin-labeled analogue of ADP with platelet-aggregating activity.
    Robey FA; Jamieson GA; Hunt JB
    J Biol Chem; 1979 Feb; 254(4):1114-8. PubMed ID: 33181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.